Skip to main content

About Cognos

Who we are

Cognos Therapeutics is a high technology medical technology company specializing in innovative drug delivery solutions. Our flagship product, SINNAIS™, is a fully implantable drug delivery pump that features an AI-enabled feedback loop for localized drug administration, complemented by metronomic and biofeedback capabilities. We focus on directly delivering drugs to specific brain regions, effectively addressing the challenge of bypassing the blood-brain barrier (BBB) for conditions like Alzheimer’s disease and brain cancers.

Additionally, we are developing a streamlined treatment for Alzheimer’s using our Microdialysis of Brain technology. Cognos operates on a licensing and partnering model, targeting drug delivery challenges in hard-to-reach areas of the body and supporting disease models requiring continuous, long-term drug administration.

Committed to driving innovation

Our flagship product, the SINNAIS™ Implantable Smart Pump, is the result of over a decade and a half of research and development in the field of implantable drug delivery pumps. SINNAIS™ represents a platform designed for the future, incorporating microelectronics, AI chips, communication capabilities, and embedded programmable parameters in its architecture.

Leading the convergence of science, data, and technology

At Cognos Therapeutics, our mission is to develop and commercialize medical products that combine diagnostic, therapeutic, and sensing technologies. Artificial intelligence (AI) has rapidly reshaped various industries, with healthcare being one of the most significant areas of impact.

Cognos is driving forward innovative solutions to address the high-burden, high-cost challenges of neurological diseases by leveraging real-time data analytics and AI to enhance patient outcomes and improve cost efficiency in healthcare delivery.

Applications of AI in medical therapeutics

The applications of AI in medical therapeutics and diagnostics are particularly noteworthy. By incorporating AI technologies in the SINNAIS™ microprocessors system, Cognos is setting new standards in therapeutics and diagnostic accuracy and treatment planning, ensuring that patients receive timely and precise care. For example, patients with Alzheimer’s requires accurate does of drugs to be administered on-time.

The SINNAIS™ AI system optimizes healthcare workflows, reduces costs, and elevates patient experience. Cognos' leadership in AI-driven technology empowers the SINNAIS™ Smart Implantable Pump to enhance patient outcomes with precision, advancing the standard of care in healthcare.